LPL Financial
MBOT icon

LPL Financial’s Microbot Medical MBOT Stock Holding History

LPL Financial’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.5K Sell
34,649
-13,283
-28% -$29.7K ﹤0.01% 5707
2025
Q4 		$95.9K Sell
47,932
-1,973
-4% -$4.67K ﹤0.01% 5604
2025
Q3 		$152K Buy
49,905
+5,459
+12% +$17K ﹤0.01% 5420
2025
Q2 		$112K Buy
+44,446
New +$106K ﹤0.01% 5246
2015
Q3 		– Sell
-7
Closed -$6K – 2856
2015
Q2 		$6K Hold
7
– – ﹤0.01% 2861
2015
Q1 		$11K Hold
7
– – ﹤0.01% 2766
2014
Q4 		$11K Hold
7
– – ﹤0.01% 2703
2014
Q3 		$14K Buy
+7
New +$18.5K ﹤0.01% 2676

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

LPL Financial's MBOT Position: Q1 2026 in Review

LPL Financial reduced its Microbot Medical (MBOT) stake by 28% in Q1 2026, selling an estimated $29.7K and leaving 34,649 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5707.

LPL Financial first reported a position in MBOT in Q3 2014 and has held it in 8 quarters since. The position peaked at $152K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • LPL Financial held 34,649 shares of Microbot Medical worth $83.5K as of Q1 2026.
  • LPL Financial sold 13,283 Microbot Medical shares in Q1 2026, an estimated $29.7K.
  • Microbot Medical made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5707 holding.
  • LPL Financial first reported a position in Microbot Medical in Q3 2014 and has held it in 8 quarters since.
  • LPL Financial's Microbot Medical position peaked at $152K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.